Literature DB >> 17016851

Unexpected inhibitory regulation of glutamate release from rat cerebrocortical nerve terminals by presynaptic 5-hydroxytryptamine-2A receptors.

Su-Jane Wang1, Kai-Yun Wang, Wei-Chieh Wang, Talvinder S Sihra.   

Abstract

Presynaptic 5-HT(2A) receptor modulation of glutamate release from rat cerebrocortical nerve terminals (synaptosomes) was investigated by using the 5-HT(2A/2C) receptor agonist (+/-)-1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI). DOI potently inhibited 4-aminopyridine (4AP)-evoked glutamate release. Involvement of presynaptic 5-HT(2A) receptors in this modulation of 4AP-evoked release was confirmed by blockade of the DOI-mediated inhibition by the 5-HT(2A) receptor antagonist ketanserin but not by the 5-HT(2C) receptor antagonist RS102221. Inhibition of glutamate release by DOI was associated with a reduction of 4AP-evoked depolarization and downstream elevation of cytoplasmic free calcium concentration ([Ca(2+)](C)) mediated via P/Q- and N-type voltage-dependent Ca(2+) channels (VDCCs). In contrast to the DOI effect on 4AP-evoked release, the agonist had no effect on high external [K(+)] (30 mM)-induced (KCl) stimulation of VDCCs or glutamate release. Likewise, release mediated by direct Ca(2+) entry with Ca(2+) ionophore (ionomycin) or by hypertonic sucrose was unaffected by DOI. Mechanistically, DOI modulation of 4AP-evoked glutamate release appeared to involve a phospholipase C/protein kinase C signaling cascade, insofar as pretreatment of synaptosomes with the phospholipase C inhibitor U73122 or protein kinase C inhibitors Ro320432 or GF109203X all effectively occluded the inhibitory effect of the agonist. Together, these results suggest that presynaptic 5-HT(2A) receptors present on glutamatergic terminals effect an unexpected depression of glutamate release by negatively modulating nerve terminal excitability and downstream VDCC activation through a signaling cascade involving phospholipase C/protein kinase C. These observations invoke presynaptic inhibitory 5-HT(2A) receptor function as a potential target for drugs to mitigate the effects of excessive glutamatergic transmission.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17016851     DOI: 10.1002/jnr.21060

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  6 in total

1.  Neuromodulatory changes in short-term synaptic dynamics may be mediated by two distinct mechanisms of presynaptic calcium entry.

Authors:  Myongkeun Oh; Shunbing Zhao; Victor Matveev; Farzan Nadim
Journal:  J Comput Neurosci       Date:  2012-06-19       Impact factor: 1.621

2.  Neuropeptide S selectively inhibits the release of 5-HT and noradrenaline from mouse frontal cortex nerve endings.

Authors:  L Raiteri; E Luccini; C Romei; S Salvadori; G Calò
Journal:  Br J Pharmacol       Date:  2009-04-03       Impact factor: 8.739

3.  The 5-Hydroxytryptamine signaling map: an overview of serotonin-serotonin receptor mediated signaling network.

Authors:  Apeksha Sahu; Lathika Gopalakrishnan; Nayana Gaur; Oishi Chatterjee; Praseeda Mol; Prashant Kumar Modi; Shobha Dagamajalu; Jayshree Advani; Sanjeev Jain; T S Keshava Prasad
Journal:  J Cell Commun Signal       Date:  2018-07-24       Impact factor: 5.782

4.  Blockade of nucleus accumbens 5-HT2A and 5-HT2C receptors prevents the expression of cocaine-induced behavioral and neurochemical sensitization in rats.

Authors:  Avi E Zayara; Gregor McIver; Paola N Valdivia; Kevin D Lominac; Andrew C McCreary; Karen K Szumlinski
Journal:  Psychopharmacology (Berl)       Date:  2010-09-03       Impact factor: 4.530

5.  Neurochemicals involved in medullary control of common carotid blood flow.

Authors:  Chi-Li Gong; Yuk-Man Leung; Ming-Ren Wang; Nai-Nu Lin; Tony Jer-Fu Lee; Jon-Son Kuo
Journal:  Curr Neuropharmacol       Date:  2013-09       Impact factor: 7.363

6.  Presynaptic 5-HT2A-mGlu2/3 Receptor-Receptor Crosstalk in the Prefrontal Cortex: Metamodulation of Glutamate Exocytosis.

Authors:  Alice Taddeucci; Guendalina Olivero; Alessandra Roggeri; Claudio Milanese; Francesco Paolo Di Giorgio; Massimo Grilli; Mario Marchi; Beatrice Garrone; Anna Pittaluga
Journal:  Cells       Date:  2022-09-28       Impact factor: 7.666

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.